Table 5.

Predictors of 6-week mortality in all patients with yeast bloodstream infections.

Characteristics	HR (95% CI)	P	Adjusted HR (95% CI)	P
Male sex	2.05 (0.78–5.39)	.15	…	.83
Diabetes mellitus	1.93 (0.76–4.93)	.17	…	.35
Refractory neutropenia	11.24 (4.15–30.42)	<.001	61.49 (10.25–368.85)	<.001
Source of infection, genitourinary tract	2.32 (0.67–7.99)	.18	…	.59
Candida glabrata	2.09 (0.75–5.86)	.16	…	.92
Pitt bacteremia score	1.63 (1.32–2.02)	<.001	1.89 (1.14–3.11)	.013
Inappropriate antifungal regimen	2.50 (1.01–6.15)	.05	…	.41
Delay in initiation of antifungal therapy >48 h	2.66 (1.07–6.62)	.04	…	.37
Retention of a central venous catheter	2.15 (0.80–5.78)	.13	…	.99
Breakthrough infection	2.62 (0.86–7.99)	.09	…	.28

CI, confidence interval; HR, hazard ratio.